Gadolinium chloride toxicity in the mouse

Human and Experimental Toxicology

Volumn 17, Issue 11, 1998, Pages 633-637

  Spencer, Andrew ^a   Wilson, Susan ^a   Harpur, Ernest ^a  

^a Alnwick Research Centre   (United Kingdom)

Author keywords

Gadolinium; Liver; Mineralisation; Mouse; Necrosis; Spleen

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GADOLINIUM CHLORIDE; GLOBULIN; LACTATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; EMBOLISM; FEMALE; HISTOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LIVER NECROSIS; MALE; MINERALIZATION; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTE; PRIORITY JOURNAL; SPLEEN;

EID: 0031743181     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719801701108     Document Type: Article

References (15)

1. 3 and Gd-DTPA and their influence on proton magnetic relaxation in rats tissues. Magnetic Resonance Imaging 1987; 5: 221-231.
2. Evans, CH. Biochemistry of the lanthanides. Plenum Press, New York 1990; pp 339-417.
3. Weinmann H-J, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. American Journal of Roentgenology 1984; 142: 619-624.
4. Harpur ES et al. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Investigative Radiology 1993; 28 (Suppl.1): 28-43.
5. Wasserman AJ et al. Utilization of electron probe microanalysis in gadolinium-treated mice. Toxicologic Pathology 1996; 24: 588-594.
6. Caille JM, Lemanceau B, Bonnemain B. Gadolinium as a contrast agent for NMR. American Journal of Roentgenology 1983; 4: 1041-1042.
7. Bruce DW, Hietbrink BE, DuBois KP. The acute mammalian toxicity of rare earth nitrates and oxides. Toxicology and Applied Pharmacology 1963; 5: 750-759.
8. Dean PB, Niemi P, Kivisaari L, Kormano M. Comparative pharmacokinetics of gadolinium DTPA and gadolinium chloride. Investigative Radiology 1988; 23 (Suppl.1): 258-260.
9. Graca JG, Davison FC, Feavel JB. Comparative toxicity of stable rare earth compounds III. Acute toxicity of intravenous injections of chlorides and chelates in dogs. Archives of Environmental Health 1964; 8: 555-564.
10. Haley TJ, Raymond K, Komesu N, Upham HC. Toxicological and pharmacological effects of gadolinium and samarium chloride. British Journal of Pharmacology 1961; 17: 526-532.
11. Husztik E, Lazar G, Parducz A. Electron microscopic study of Kupffer-cell phagocytosis blockage induced by gadolinium chloride. British Journal of Experimental Pathology 1980; 61: 624-630.
12. Lazar G. The reticuloendothelial-blocking effect of rare earth metals in rats. Journal of The Reticuloendothelial Society 1973; 13: 231-237.
13. Selye H, Szabo S, Tuchweber B, Lefebvre F. Acute miliary necrosis resembling peliosis hepatis produced by the combination of glucocorticoid and gadolinium chloride. Proceedings of the Society of Experimental Biology and Medicine 1972; 139: 887-889.
14. Spencer, AJ et al. Gadolinium chloride toxicity in the rat. Toxicologic Pathology 1997; 25: 245-255.
15. Rees, JA et al. Time course of stomach mineralisation, plasma and urinary changes after a single intravenous administration of gadolinium (III) chloride in the male rat. Toxicologic Pathology 1997; 25: 582-589.